Quarterly Result19 May 2025, 10:04 pm
Innova Captab Ltd Reports 20% YoY Revenue Growth and 3% PAT Growth in Q4 FY25
AI Summary
Innova Captab Limited, a leading integrated pharmaceutical company, reported healthy results for Q4 FY25 with Revenue from Operations at ₹ 314.7 crores and Profit After Tax (PAT) at ₹ 29.6 crores. The company registered a YoY revenue growth of 20% and PAT growth of 3%. The Kathua, Jammu plant, commercialized in January 2025, contributed to the growth despite associated depreciation and finance costs.
Key Highlights
- Revenue from Operations grew by 20% YoY to ₹ 314.7 crores
- PAT rose by 3% YoY to ₹ 29.6 crores
- EBITDA registered a stellar growth of 17% YoY
- FY25 saw a revenue growth of 15% and PAT growth of 36%
- Commissioning of Kathua, Jammu facility enabled scaled production of new products and dosage forms